Cholesterol-lowering drugs and Alzheimer’’s disease

Author： Eckert Gunter P   Müüller Walter E   Wood W Gibson  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.2, Iss.4, 2007-08, pp. : 423-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholesterol and ApoE in Alzheimer’s disease

By Potier Marie-Claude   Hanbouch Linda   Marquer Catherine  

OCL (Oilseeds, Crops, fats & Lipids), Vol. 25, Iss. 4, 2018-08 ,pp. : D407-D407

Edp Sciences

Access to resources Recommend Favorite

The Ebbs and Flows in the Development of Cholesterol‐Lowering Drugs: Prospects for the Future

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 64-73

John Wiley & Sons Inc

Access to resources Recommend Favorite

Memory enhancing drugs and Alzheimer’s Disease: Enhancing the self or preventing the loss of it?

By Dekkers Wim   Rikkert Marcel  

Medicine, Health Care and Philosophy, Vol. 10, Iss. 2, 2007-06 ,pp. : 141-151

Springer Publishing Company

Access to resources Recommend Favorite

Pain and Alzheimer’s Disease

By  

Gerontology, Vol. 46, Iss. 5, 2000-08 ,pp. : 235-241

Karger

Access to resources Recommend Favorite

Somatotype in Alzheimer’s Disease

By  

Gerontology, Vol. 53, Iss. 4, 2007-03 ,pp. : 200-204

Karger

Access to resources Recommend Favorite